Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06733077

Development of Digital Diagnostics and Intervention Services for Parkinson's Disease

Led by University of Exeter · Updated on 2025-02-03

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Exeter

Lead Sponsor

U

University of Zurich

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating digital tools to improve diagnosis and monitoring of Parkinson's disease (PD), a common neurodegenerative disorder affecting many older adults. The study focuses on collecting eye movement, pupil response, and walking pattern data from people with PD to develop machine learning models. These models aim to provide earlier and more precise diagnosis and track disease progression better than current methods that rely on subjective assessments. Participants will undergo several phases including laboratory testing and home monitoring. Eye and pupil data will be collected using standard clinical exams and a medical device called Neos. Gait data will be gathered through wearable sensors including an IMU sensor and the GaitQ senti device, which allows continuous remote monitoring. Some participants will also experience a two-week home intervention using a vibration-based cueing device to assess its potential effects on gait. During the study, participants will complete various walking and motor tests such as the Timed Up and Go test and Sit to Stand test across two lab visits spaced up to three weeks apart. Researchers will monitor safety and usability of the devices over up to six weeks. Data collected will be analyzed against clinical assessments to develop and compare machine learning models, contributing to better understanding and personalized care for people with Parkinson's disease.

CONDITIONS

Brief Title

Development of Digital Services for Parkinson's Disease

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of idiopathic Parkinson's disease or similar condition such as stroke, multiple sclerosis, arthritis, or osteoporosis
  • Able to self-report history of daily gait freezing or festination (for people with Parkinson's)
  • Able to walk unsupported or with an aid for at least 5 minutes
  • Adult aged 18 years or older
  • Normal or corrected-to-normal vision or safe to mobilize with support
  • Montreal Cognitive Assessment score greater than 21 or ability to follow two-step commands
  • Healthy participants must have no long-term conditions affecting movement
  • Healthy participants able to walk unsupported or with an aid for at least 3 minutes
  • Healthy participants must meet the same vision and cognitive requirements as above
Not Eligible

You will not qualify if you...

  • Any physical or mental condition preventing safe participation or understanding of testing
  • Cognitive impairment affecting safe participation and ability to follow instructions
  • Any injury or disorder affecting balance, other than Parkinson's or related primary condition
  • Skin conditions or broken skin on the calf or behind the knee
  • Deep brain stimulation, pacemaker implants, or other implants interfering with measurement devices
  • Use of medications likely to affect eyesight or virtual reality system (for Parkinson's participants)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 6 weeks

Participants undergo sequential phases involving lab and home/community testing to collect gait and ocular motor data using digital devices, including MachineMD and gaitQ, to assess feasibility and develop intervention services for Parkinson's disease.

2 lab visits of approximately 2 hours each and daily home/community testing for 2 weeks per home phase

Trial Site Locations

Total: 1 location

1

University of Exeter

Exeter, United Kingdom, EX1 2LU

Actively Recruiting

Loading map...

Research Team

P

Pavlos Evangelidis, PhD

H

Helen Dawes, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

A Randomized, Double-blind, Placebo-controlled, Single-ascen...

Parkinson's Disease

Actively Recruiting

4 locations

A Clinical Trial of Parkinson's Disease Treatment by Human-i...

Parkinson's Disease

Actively Recruiting

2 locations

A Multicenter, Sham-controlled, Randomized Study to Evaluate...

Parkinson's Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here